Literature DB >> 17050284

Etiology of vision loss in ganglioside GM3 synthase deficiency.

Fahhad Farukhi1, Claudia Dakkouri, Heng Wang, Max Wiztnitzer, Elias I Traboulsi.   

Abstract

PURPOSE: To investigate the cause of vision loss in patients with ganglioside GM3 synthase deficiency, a newly described rare autosomal recessive infantile-onset symptomatic epilepsy syndrome associated with developmental stagnation and blindness.
METHODS: We examined four children from two related Amish sibships. Molecular genetic analysis confirmed inheritance of the founder mutation. Electroretinography and fundus photography were obtained in two patients.
RESULTS: Despite an initial suspicion of retinal degeneration, retinal function was found to be preserved in both patients and ERG amplitudes were within normal limits. Ophthalmoscopy showed bilateral optic atrophy in all patients.
CONCLUSIONS: Vision loss in GM3 synthase deficiency results from central nervous system and optic nerve involvement. Retinal function appears to be otherwise normal into the teenage years.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17050284     DOI: 10.1080/13816810600862626

Source DB:  PubMed          Journal:  Ophthalmic Genet        ISSN: 1381-6810            Impact factor:   1.803


  10 in total

1.  ST3GAL5-Related Disorders: A Deficiency in Ganglioside Metabolism and a Genetic Cause of Intellectual Disability and Choreoathetosis.

Authors:  Eliza Gordon-Lipkin; Julie S Cohen; Siddharth Srivastava; Bruno P Soares; Eric Levey; Ali Fatemi
Journal:  J Child Neurol       Date:  2018-09-05       Impact factor: 1.987

Review 2.  Human genetic disorders of sphingolipid biosynthesis.

Authors:  Leonardo Astudillo; Frédérique Sabourdy; Nicole Therville; Heiko Bode; Bruno Ségui; Nathalie Andrieu-Abadie; Thorsten Hornemann; Thierry Levade
Journal:  J Inherit Metab Dis       Date:  2014-08-21       Impact factor: 4.982

3.  Refractory epilepsy and mitochondrial dysfunction due to GM3 synthase deficiency.

Authors:  Konstantina Fragaki; Samira Ait-El-Mkadem; Annabelle Chaussenot; Catherine Gire; Raymond Mengual; Laurent Bonesso; Marie Bénéteau; Jean-Ehrland Ricci; Valérie Desquiret-Dumas; Vincent Procaccio; Agnès Rötig; Véronique Paquis-Flucklinger
Journal:  Eur J Hum Genet       Date:  2012-09-19       Impact factor: 4.246

Review 4.  Functional roles of gangliosides in neurodevelopment: an overview of recent advances.

Authors:  Robert K Yu; Yi-Tzang Tsai; Toshio Ariga
Journal:  Neurochem Res       Date:  2012-03-13       Impact factor: 3.996

5.  Ganglioside GM3 is essential for the structural integrity and function of cochlear hair cells.

Authors:  Misato Yoshikawa; Shinji Go; Shun-ichi Suzuki; Akemi Suzuki; Yukio Katori; Thierry Morlet; Steven M Gottlieb; Michihiro Fujiwara; Katsunori Iwasaki; Kevin A Strauss; Jin-ichi Inokuchi
Journal:  Hum Mol Genet       Date:  2015-02-04       Impact factor: 6.150

6.  Routine Orthoptic-led Paediatric Fundus Digital Imaging: Benefits to Patients and Healthcare System.

Authors:  Laura B Ramm; Clare Bradbury; Manoj V Parulekar
Journal:  Br Ir Orthopt J       Date:  2018-04-24

Review 7.  Glycosylation diseases: quo vadis?

Authors:  Harry Schachter; Hudson H Freeze
Journal:  Biochim Biophys Acta       Date:  2008-11-13

8.  Oral Ganglioside Supplement Improves Growth and Development in Patients with Ganglioside GM3 Synthase Deficiency.

Authors:  Heng Wang; Valerie Sency; Paul McJarrow; Alicia Bright; Qianyang Huang; Karen Cechner; Julia Szekely; JoAnn Brace; Andi Wang; Danting Liu; Angela Rowan; Max Wiznitzer; Aimin Zhou; Baozhong Xin
Journal:  JIMD Rep       Date:  2018-09-13

Review 9.  Simplifying complexity: genetically resculpting glycosphingolipid synthesis pathways in mice to reveal function.

Authors:  Maria Laura Allende; Richard L Proia
Journal:  Glycoconj J       Date:  2014-10-29       Impact factor: 2.916

Review 10.  Roles of Gangliosides in Hypothalamic Control of Energy Balance: New Insights.

Authors:  Kei-Ichiro Inamori; Jin-Ichi Inokuchi
Journal:  Int J Mol Sci       Date:  2020-07-28       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.